Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 23, Issue 2, Pages e75-e87
Publisher
Elsevier BV
Online
2022-02-01
DOI
10.1016/s1470-2045(21)00657-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
- (2021) Hugo Levillain et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
- (2021) Michael S Hofman et al. LANCET
- Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms
- (2021) Ulrika Jahn et al. Cancers
- To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer
- (2021) Joey Roosen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
- (2021) Florian Rosar et al. EJNMMI Physics
- Dosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE
- (2021) Daniel Roth et al. JOURNAL OF NUCLEAR MEDICINE
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radioembolization for the Treatment of Hepatocellular Carcinoma: The Road to Personalized Dosimetry and Ablative Practice
- (2021) Cynthia De la Garza-Ramos et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- OpenDose: open access resources for nuclear medicine dosimetry
- (2020) Maxime Chauvin et al. JOURNAL OF NUCLEAR MEDICINE
- Larotrectinib-Enhanced Radioactive Iodine Uptake in Advanced Thyroid Cancer
- (2020) Lionel Groussin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overcoming Barriers to Radiopharmaceutical Therapy: An Overview from the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy (RPT)
- (2020) Chaitanya Divgi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A novel time-activity information sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: application in SPECT/CT imaging post-177Lu-DOTATATE
- (2020) Theresa Devasia et al. JOURNAL OF NUCLEAR MEDICINE
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
- (2020) Etienne Garin et al. Lancet Gastroenterology & Hepatology
- Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT
- (2019) Youngho Seo et al. MEDICAL PHYSICS
- Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group
- (2019) Riad Salem et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy
- (2019) Marilyne Kafrouni et al. EJNMMI Research
- Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177 Lu-Satoreotide Tetraxetan
- (2019) Diane Reidy-Lagunes et al. CLINICAL CANCER RESEARCH
- Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Post-treatment SPECT/CT: A Novel Methodology to Generate Time- and Tissue-specific Dose Factors
- (2019) Price A Jackson et al. JOURNAL OF NUCLEAR MEDICINE
- Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma
- (2018) Ambreen Khawar et al. CLINICAL NUCLEAR MEDICINE
- Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
- (2018) Marta Cremonesi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
- (2018) Ulrike Garske-Román et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma
- (2018) Keith T. Chan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- 90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy
- (2018) Yusuf Menda et al. JOURNAL OF NUCLEAR MEDICINE
- The relevance of dosimetry in precision medicine
- (2018) Michael Lassmann et al. JOURNAL OF NUCLEAR MEDICINE
- Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review
- (2018) Daphne Merel Valerie Huizing et al. EJNMMI Research
- Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
- (2018) Michela Del Prete et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Efficacy and Safety of High-Specific-Activity I-131 MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
- (2018) Daniel A. Pryma et al. JOURNAL OF NUCLEAR MEDICINE
- Dosimetry of Lu-177 PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pre-therapeutic imaging and “whole body” tumor dosimetry with treatment outcomes
- (2018) John A Violet et al. JOURNAL OF NUCLEAR MEDICINE
- The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
- (2017) Lorenza Scarpa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
- (2017) Anna Sundlöv et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
- (2017) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer
- (2017) Madhav P. Yadav et al. NUCLEAR MEDICINE COMMUNICATIONS
- Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer
- (2017) Florian C. Gaertner et al. Oncotarget
- Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review
- (2017) Tiantian Li et al. Theranostics
- Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
- (2017) David LH Chan et al. Theranostics
- Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
- (2016) Hendrik Bergsma et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiation Dosimetry for 177 Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
- (2016) Shozo Okamoto et al. JOURNAL OF NUCLEAR MEDICINE
- Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison
- (2016) S. Gnesin et al. JOURNAL OF NUCLEAR MEDICINE
- PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
- (2016) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with90Y-loaded glass microsphere radioembolization
- (2016) Etienne Garin et al. LIVER INTERNATIONAL
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
- (2015) Levent Kabasakal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
- (2015) Andreas Delker et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors
- (2015) H. Ilhan et al. JOURNAL OF NUCLEAR MEDICINE
- Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE
- (2015) E. Ilan et al. JOURNAL OF NUCLEAR MEDICINE
- MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy
- (2015) M. Ljungberg et al. JOURNAL OF NUCLEAR MEDICINE
- PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy
- (2015) Yoo Sung Song et al. MEDICINE
- Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of131I
- (2015) Frank Atkins et al. THYROID
- Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
- (2014) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
- (2014) Lidia Strigari et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
- (2014) Christian M. Zechmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
- (2014) Shih-ying Huang et al. MOLECULAR IMAGING AND BIOLOGY
- Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
- (2013) E. Garin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In vivo dosimetry in external beam radiotherapy
- (2013) Ben Mijnheer et al. MEDICAL PHYSICS
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
- (2013) Alan L. Ho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kidney Dosimetry in177Lu and90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors
- (2013) F. Guerriero et al. Biomed Research International
- MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy
- (2012) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
- (2012) E. B. Silberstein et al. JOURNAL OF NUCLEAR MEDICINE
- Minor changes in effective half-life during fractionated177Lu-Octreotate therapy
- (2011) Ulrike Garske et al. ACTA ONCOLOGICA
- Absolute Quantification of [11C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography
- (2011) A. A. M. van der Veldt et al. CLINICAL CANCER RESEARCH
- Severe Dry Eye Syndrome After Radiotherapy for Head-and-Neck Tumors
- (2011) Niranjan Bhandare et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Efficacy of DosimetricVersusEmpiric Prescribed Activity of131I for Therapy of Differentiated Thyroid Cancer
- (2011) Joanna Klubo-Gwiezdzinska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Dosimetry and thyroid cancer: the individual dosage of radioiodine
- (2010) Michael Lassmann et al. ENDOCRINE-RELATED CANCER
- EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting
- (2010) M. Lassmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry
- (2010) Cecilia Hindorf et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiation-Associated Kidney Injury
- (2010) Laura A. Dawson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation dose estimation using preclinical imaging with I124-metaiodobenzylguanidine (MIBG) PET
- (2010) Chang-Lae Lee et al. MEDICAL PHYSICS
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry--Standardization of Nomenclature
- (2009) W. E. Bolch et al. JOURNAL OF NUCLEAR MEDICINE
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
- (2008) W. Jentzen et al. JOURNAL OF NUCLEAR MEDICINE
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy
- (2008) B. W. Wessels et al. JOURNAL OF NUCLEAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now